The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hepatic arterial infusion chemotherapy after sorafenib treatment in patients with advanced hepatocellular carcinoma who are unfit for regorafenib.
 
Takeshi Terashima
Research Funding - Bayer (Inst); Eisai (Inst)
 
Tatsuya Yamashita
Speakers' Bureau - Bayer; Eisai
 
Noboru Takata
Research Funding - Bayer (Inst); Eisai (Inst)
 
Kuniaki Arai
Research Funding - Bayer (Inst); Eisai (Inst)
 
Eishiro Mizukoshi
Research Funding - Bayer (Inst); Eisai (Inst)
 
Shuichi Kaneko
Consulting or Advisory Role - Bayer; Eisai
Speakers' Bureau - Bayer; Eisai
Research Funding - Bayer (Inst); Eisai (Inst)